VERV: Verve Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 455.49
Enterprise Value ($M) 296.78
Book Value ($M) 508.55
Book Value / Share 6.01
Price / Book 0.90
NCAV ($M) 401.10
NCAV / Share 4.74
Price / NCAV 1.14

Profitability (mra)
Return on Invested Capital (ROIC) -0.34
Return on Assets (ROA) -0.32
Return on Equity (ROE) -0.43

Liquidity (mrq)
Quick Ratio 13.05
Current Ratio 13.05

Balance Sheet (mrq) ($M)
Current Assets 556.46
Assets 663.91
Liabilities 155.35
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
4 days ago 13G/A Vanguard Group Inc 4.73 0.00
8 days ago 13G/A BlackRock, Inc. 8.60 0.00
10-16 13G State Street Corp 5.00 9.99
09-09 13G/A Millennium Management Llc 6.30 24.74
01-29 13G/A ARK Investment Management LLC 8.74 60.91
12-11 13G/A Gv 2017, L.p. 15.40 17.06
12-11 13G/A Fmr Llc 4.84 -44.92

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 435,700 1,683,113 25.89
2024-11-14 261,905 1,149,633 22.78
2024-11-13 177,988 1,059,091 16.81
2024-11-12 216,526 1,074,211 20.16
2024-11-11 164,056 5,206,845 3.15

(click for more detail)

Similar Companies
TYRA – Tyra Biosciences, Inc. UBX – Unity Biotechnology, Inc.
UTHR – United Therapeutics Corporation VIGL – Vigil Neuroscience, Inc.
VIR – Vir Biotechnology, Inc.


Financial data and stock pages provided by
Fintel.io